Randomised Phase II Study of Cyclophosphamide, Doxorubicin and Vincristine compared with Single-Agent Carboplatin in Patients with Poor Prognosis Small Cell Lung Carcinoma

Autoria(s): White, S.; Lorigan, P.; Middleton, M.; Anderson, H.; Valle, J.; Summers, Yvonne; Burt, P.; Arance, A.; Stout, R.; Thatcher, N.
Data(s)

01/04/2001
Identificador

http://pure.qub.ac.uk/portal/en/publications/randomised-phase-ii-study-of-cyclophosphamide-doxorubicin-and-vincristine-compared-with-singleagent-carboplatin-in-patients-with-poor-prognosis-small-cell-lung-carcinoma(3f65c787-6e1d-4af8-9d64-180d92c13f31).html

http://dx.doi.org/10.1002/1097-0142(20010801)92:3<601::AID-CNCR1360>3.0.co;2-k
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

White , S , Lorigan , P , Middleton , M , Anderson , H , Valle , J , Summers , Y , Burt , P , Arance , A , Stout , R & Thatcher , N 2001 , ' Randomised Phase II Study of Cyclophosphamide, Doxorubicin and Vincristine compared with Single-Agent Carboplatin in Patients with Poor Prognosis Small Cell Lung Carcinoma ' Cancer , vol 92 (3) , pp. 601-608 . DOI: 10.1002/1097-0142(20010801)92:3<601::AID-CNCR1360>3.0.co;2-k
Tipo

article
Acesso ao item digital